Ren Wei
CIK: 0002123015
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Wei Ren
Wei Ren (SEC CIK 0002123015) files insider reports with the SEC as Director of ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG).
Signal8 holds 1 ownership filing by Wei Ren, a Form 3, filed on Mar 23, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Wei Ren's filings is in ROCKVILLE, MD.
Other insiders filing for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
- Miyara Faical, Chief Business Officer
- Zhai Yifan, Chief Medical Officer
- Yang Dajun, Chairman and CEO
- Misra Veet, Chief Financial Officer
- Cao Jin, Chief Accounting Officer
- Ye Changqing, Director